{"id":3795,"date":"2021-03-13T09:00:00","date_gmt":"2021-03-13T15:00:00","guid":{"rendered":"https:\/\/blog.unmc.edu\/infectious-disease\/?p=3795"},"modified":"2021-03-12T11:31:03","modified_gmt":"2021-03-12T17:31:03","slug":"unmc-id-at-croi-2021","status":"publish","type":"post","link":"https:\/\/blog.unmc.edu\/infectious-disease\/2021\/03\/13\/unmc-id-at-croi-2021\/","title":{"rendered":"UNMC ID at #CROI 2021"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"321\" height=\"139\" src=\"https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2021\/03\/CROI.jpg\" alt=\"\" class=\"wp-image-3796\" srcset=\"https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2021\/03\/CROI.jpg 321w, https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2021\/03\/CROI-300x130.jpg 300w, https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2021\/03\/CROI-120x52.jpg 120w\" sizes=\"auto, (max-width: 321px) 100vw, 321px\" \/><\/figure>\n\n\n\n<p>Conferences may continue to look different due to the COVID-19 pandemic, but our ID faculty remain dedicated as ever to continuing to contribute to scientific knowledge and advancement of patient care. The <a href=\"https:\/\/www.croiconference.org\/\">Conference on Retroviruses and Opportunistic Infections  (CROI)<\/a> was held this year from March 6-10, and UNMC had several presentations. See below for the highlights and check out the conference for more details!<\/p>\n\n\n\n<p>130 RIFAPENTINE +\/\u2013 MOXIFLOXACIN FOR PULMONARY TUBERCULOSIS INPEOPLE WITH HIV April Pettit, Payam Nahid, Patrick P. Phillips, Andrew Vernon, Ekaterina Kurbatova, Rodney Dawson, Ian Sanne, Ziyaad Waja, Lerato Mohapi, Wadzana,Samaneka, John Johnson, Susan Dorman, Richard E. Chaisson,\u00a0Susan Swindells, for TBTC Study 31\/ACTG 5349 study team<\/p>\n\n\n\n<p>178 ADVERSE PREGNANCY OUTCOMES AMONG HIV-INFECTED WOMEN EXPOSED TO ISONIAZID IN BRIEF-TB Amita Gupta, Michael Hughes, Jorge T. Leon-Cruz, Anchalee Avihingsanon, Noluthando Mwelase,Patrice Severe, Ayotunde Omoz-Oarhe, Gaerolwe Masheto, Laura Moran, Constance A. Benson,Richard E. Chaisson,\u00a0Susan Swindells, for the ACTG 5279 BRIEF TB Trial<\/p>\n\n\n\n<p>505 WEIGHT AND LIPID CHANGES IN PHASE 3 CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING TRIAL Parul Patel, Ronald D&#8217;Amico, Shanker Thiagarajah, Sterling Wu, Emilie Elliot, Joseph W. Polli, Ojesh Upadhyay, Rodica Van Solingen-Ristea, Chloe Orkin, E. Turner Overton,\u00a0Susan Swindells, Jean A. Van Wyk, Matthew Bosse, Vani Vannappagari<\/p>\n\n\n\n<p>91 PK OF DOSE-ADJUSTED EMERGENCY CONTRACEPTION WITH EFV-BASED ART IN ACTG 5375 Kimberly K. Scarsi, Laura M. Smeaton, Anthony T. Podany, Maxine Olefsky, Elizabeth Woolley, Elizabeth Barr, Kayla Campbell, Sivaporn Gatechompol, Jeffrey Jeppson, Sajeeda Mawlana, Khuanchai Supparatpinyo, Catherine Godfrey, Susan E. Cohn, Rosie Mngqibisa, for the AIDS Clinical Trials Group A5375 Study Team<\/p>\n\n\n\n<p>368 PHARMACOKINETICS OF 2 CONTRACEPTIVE IMPLANTS AMONG WOMEN ON RILPIVIRINE-BASED ART Shadia Nakalema, Catherine A. Chappell, Michelle Pham, Ritah Nakijoba,Leah Mbabazi, Pauline Byakika-Kibwika, Julian Kaboggoza, Stephen I. Walimbwa, Jeffrey Jeppson, Lee Winchester, Marco Siccardi,\u00a0Courtney V. Fletcher, Kimberly K. Scarsi, Mohammed Lamorde<\/p>\n\n\n\n<p>359 PERSISTENT HIV TRANSCRIPTION AND VARIABLE ARV LEVELS IN LYMPH NODES DURING ART Courtney V. Fletcher, Eugene Kroon, Timothy Schacker, Suteeraporn Pinyakorn, Nicolas Chomont, Suthat Chottanapund2, Peeriya Prueksakaew, Khunthalee Benjapornpong, Supranee Buranapraditkun, Jintanat Ananworanich, Sandhya Vasan, Denise C. Hsu, for the RV254\/SEARCH 010 Study Group<\/p>\n\n\n\n<p>undefined<\/p>\n\n\n\n<p><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Conferences may continue to look different due to the COVID-19 pandemic, but our ID faculty remain dedicated as ever to continuing to contribute to scientific knowledge and advancement of patient care. The Conference on Retroviruses and Opportunistic Infections (CROI) was held this year from March 6-10, and UNMC had several presentations. See below for the [&hellip;]<\/p>\n","protected":false},"author":532,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_s2mail":"","footnotes":""},"categories":[15],"tags":[],"class_list":["post-3795","post","type-post","status-publish","format-standard","hentry","category-conferences-and-presentations"],"_links":{"self":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/3795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/users\/532"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/comments?post=3795"}],"version-history":[{"count":1,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/3795\/revisions"}],"predecessor-version":[{"id":3797,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/3795\/revisions\/3797"}],"wp:attachment":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/media?parent=3795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/categories?post=3795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/tags?post=3795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}